Literature DB >> 28204557

Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins.

Andrew M Borman1, Adrien Szekely1, Elizabeth M Johnson1.   

Abstract

Candida auris has recently emerged as a serious nosocomial health risk, with widespread outbreaks in numerous hospitals worldwide and the existence of geographic region-specific discrete clonal lineages. Here we have compared the rDNA sequences of 24 isolates of Candida auris from 14 different hospital centers in the United Kingdom with those of strains from different international origins present in the public sequence databases. Here we show that UK isolates of C. auris fall into three well-supported clades corresponding to lineages that have previously been reported from India, Malaysia and Kuwait, Japan and Korea, and South Africa, respectively. © Crown copyright 2017.

Entities:  

Keywords:  Candida auris, emerging pathogen; United Kingdom; clonal strains; pathogenic yeasts; rDNA sequencing

Mesh:

Substances:

Year:  2017        PMID: 28204557     DOI: 10.1093/mmy/myw147

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  42 in total

1.  Rapid Detection of Candida auris Based on Loop-Mediated Isothermal Amplification (LAMP).

Authors:  Mikachi Yamamoto; Mohamed Mahdi Alshahni; Takashi Tamura; Kazuo Satoh; Shigekazu Iguchi; Ken Kikuchi; Masakazu Mimaki; Koichi Makimura
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

Review 2.  Candida auris: a Review of the Literature.

Authors:  Anna Jeffery-Smith; Surabhi K Taori; Silke Schelenz; Katie Jeffery; Elizabeth M Johnson; Andrew Borman; Rohini Manuel; Colin S Brown
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

3.  Experimental Evolution Identifies Adaptive Aneuploidy as a Mechanism of Fluconazole Resistance in Candida auris.

Authors:  Jian Bing; Tianren Hu; Qiushi Zheng; José F Muñoz; Christina A Cuomo; Guanghua Huang
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris.

Authors:  Hamed Fakhim; Anuradha Chowdhary; Anupam Prakash; Afsane Vaezi; Eric Dannaoui; Jacques F Meis; Hamid Badali
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.

Authors:  Alexander J Lepak; Miao Zhao; Elizabeth L Berkow; Shawn R Lockhart; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Candida auris Isolates of the Southern Asian and South African Lineages Exhibit Different Phenotypic and Antifungal Susceptibility Profiles In Vitro.

Authors:  Adrien Szekely; Andrew M Borman; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

7.  A TaqMan Probe-Based Real-Time PCR Assay for the Rapid Identification of the Emerging Multidrug-Resistant Pathogen Candida auris on the BD Max System.

Authors:  Amorce Lima; Raymond Widen; Grant Vestal; Dominic Uy; Suzane Silbert
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

Review 8.  Candida auris: an Emerging Fungal Pathogen.

Authors:  Emily S Spivak; Kimberly E Hanson
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

9.  Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.

Authors:  Milena Kordalewska; Annie Lee; Steven Park; Indira Berrio; Anuradha Chowdhary; Yanan Zhao; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

10.  Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey.

Authors:  Nancy A Chow; Lalitha Gade; Sharon V Tsay; Kaitlin Forsberg; Jane A Greenko; Karen L Southwick; Patricia M Barrett; Janna L Kerins; Shawn R Lockhart; Tom M Chiller; Anastasia P Litvintseva
Journal:  Lancet Infect Dis       Date:  2018-10-04       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.